WU ZHANG
机构: University of Southern California/Norris Cancer Center
每年引用次数
引用次数
引用: 13,135
H-指数: 56
I10-指数 : 152
出版物: 380
Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.
Georg Lurje , Yan Ning , Wu Zhang , Alexandra Pohl
Oncology 22 ( 4) 456 -462
12
2008
A Xeroderma Pigmentosum Group D Gene Polymorphism Predicts Clinical Outcome to Platinum-based Chemotherapy in Patients with Advanced Colorectal Cancer
Denice D. Tsao-Wei , Jan Stoehlmacher , Susan Groshen , Wu Zhang
Cancer Research 61 ( 24) 8654 -8658
280
2001
Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Daniel Vallböhmer , Susan Groshen , Bo Lu , Katrin Rhodes
Clinical Cancer Research 11 ( 2) 600 -605
82
2005
Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study)
Pierre Bohanes , Georg Lurje , Yan Ning , Ellen Hollywood
Anticancer Research 30 ( 10) 4209 -4217
31
2010
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.
Denice Tsao-Wei , Jan Stoehlmacher , Susan Groshen , Wu Zhang
Clinical advances in hematology & oncology 1 ( 3) 162
123
2003
Molecular characterization of pancreatic cancers as seen in the SLUG gene revealing cancer progression.
Emil Lou , Anthony Frank Shields , Joanne Xiu , Andreas Seeber
Journal of Clinical Oncology 39 433 -433
1
2021
Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.
Chiara Cremolini , Fotios Loupakis , Alfredo Falcone , Wu Zhang
Journal of Clinical Oncology 39 118 -118
2021
GDF15 expression in metastatic colorectal cancer.
Emil Lou , Joanne Xiu , Priya Jayachandran , Wu Zhang
Journal of Clinical Oncology 39 116 -116
1
2021
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer
Chiara Cremolini , Afsaneh Barzi , Fotios Loupakis , Marta Schirripa
Pharmacogenomics Journal 21 ( 3) 1 -11
2021
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer.
Emil Lou , Chiara Cremolini , Roberto Moretto , Joanne Xiu
Clinical Cancer Research 27 ( 11) 3234 -3242
2021
RNA-binding protein polymorphisms as novel biomarkers to predict outcomes of metastatic colorectal cancer: A meta-analysis from TRIBE, FIRE-3 and MAVERICC
Chiara Cremolini , Fotios Loupakis , Shu Cao , Alfredo Falcone
Molecular Cancer Therapeutics 20 ( 6) 1153 -1160
2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer.
Chiara Cremolini , Fotios Loupakis , Priya Jayachandran , Alfredo Falcone
European Journal of Cancer 150 133 -142
2021
Effect of polymorphisms of genes encoding regulatory proteins in the coagulation cascade on outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial.
Sebastian Stintzing , Dongyun Yang , Mitsukuni Suenaga , Yuji Miyamoto
Journal of Clinical Oncology 35 601 -601
2017
Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy.
Yuji Miyamoto , Sebastian Stintzing , Wu Zhang , Shu Cao
Journal of Clinical Oncology 35 600 -600
2017
Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial.
Martin D. Berger , Sebastian Stintzing , Volker Heinemann , Dongyun Yang
Journal of Clinical Oncology 35 595 -595
2017
Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang
Journal of Clinical Oncology 35 596 -596
1
2017
Genetic variants of genes in CCL5/CCR5 pathway to predict regorafenib-induced hand-foot skin reaction in patients with refractory metastatic colorectal cancer: A report of ethnic difference.
Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang
Journal of Clinical Oncology 35 615 -615
1
2017
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Ravit Geva , Loredana Vecchione , Konstantinos T Kalogeras , Benny Vittrup Jensen
Gut 64 ( 6) 921 -928
25
2015
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer
Sebastian Stintzing , Wu Zhang , Volker Heinemann , Daniel Neureiter
Molecular Cancer Therapeutics 14 ( 10) 2374 -2381
4
2015
Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach
Yan Ning , Diana L. Hanna , Wu Zhang , Angela Mendez
Molecular Cancer Therapeutics 14 ( 10) 2401 -2408
18
2015